Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +937.0% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital / assets changed +4821 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -86.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed +2388.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed -77.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current ratio changed +1503.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Research & development changed +97.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.